Published December 30, 2025 | Version v1

Early-Life Microbiome and Its Link to Neurodevelopmental Disorders and Allergic Reactions in Newborns - A Mechanistic Insight

Description

The early life stage, encompassing the prenatal period, perinatal phase, and the initial 2–3 years, represents a crucial interval during which environmental exposures, particularly the microbiome, significantly influence the development of the immune and neurological systems. Changes in maternal, placental, and baby microbiota have been linked to later neurodevelopmental outcomes, such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), as well as allergic conditions, including eczema, food allergy, allergic rhinitis, and asthma. Observational studies and mechanistic assays indicate that metabolites derived from microbes, immunological programming, vagal and neuronal communication, and epigenetic regulation may function as potential mediators. Nonetheless, findings are varied, causal relationships are not fully established, and therapies (probiotics, prebiotics, and fecal microbiota transplantation) have inconsistent outcomes. The article integrates human epidemiologic data, animal and mechanistic studies, and intervention research; identifies limitations; and proposes research priorities to elucidate causation and safely transition results into prevention or therapy.

Files

104-Sompalli Bhavana.pdf

Files (1.0 MB)

Name Size
md5:c6388b36de6660dd1018b23db07fd55d
1.0 MB Preview Download